Benzinga | Jun 8, 2021 09:02AM EDT

Avalon GloboCare Says Will Present Its S-Layer, QTY Code Breakthrough Technology Platforms At World Stem Cell Summit

Avalon GloboCare Corp. (NASDAQ:AVCO) (Avalon or The Company), a clinical-stage global developer of cell-based technologies and therapeutics, today announces that the company's President and Chief Executive Officer, David Jin, M.D., Ph.D., will chair a session on the "Hot Topics and Future Trends" track at the 2021 Annual World Stem Cell Summit, which will take place virtually on June 14-18, 2021. The session will feature Avalon's two breakthrough technology platforms, S-layer nanotechnology and QTY code, in co-development with the Massachusetts Institute of Technology (MIT) and the University of Natural Resources and Life Sciences in Vienna (BOKU), respectively.



Avalon's collaborators and key opinion leaders, Professor Shuguang Zhang, Ph.D., of MIT's Media lab in Boston, MA and Professor Uwe B. Sleytr, Ph.D., Professor Emeritus at BOKU, member of the Austrian Academy of Sciences, and part of Avalon's Scientific and Clinical Advisory Board, are invited speakers of the session.

This featured presentation at the upcoming virtual meeting is entitled, "S-Layer and QTY Code: Promising Technologies to Transform Cellular Therapy and Regenerative Medicine."